The New Jersey Economic Development Authority (NJEDA) announced on Thursday it has closed on a $250,000 convertible note to River Edge-based InquisitHealth, to help the population health/technology company further its mission of helping patients with diabetes, asthma, hypertension, and other chronic diseases overcome the social determinants of health and adopt healthy lifestyle changes through its peer mentoring program.
The funding was provided through the NJEDA’s NJ CoVest Fund, which is designed to help emerging technology companies bridge the funding gap between product development and commercialization, and further the NJEDA’s ability to support businesses throughout their growth lifecycle. InquisitHealth, which was founded in New Jersey in 2012, plans to use this funding to significantly bolster its workforce and impact in the coming years. Read more here.